题名 | Afatinib plus vinorelbine versus trastuzumab plus vinorelbine in patients with HER2-overexpressing metastatic breast cancer who had progressed on one previous trastuzumab treatment (LUX-Breast 1): an open-label, randomised, phase 3 trial |
链接 | http://www.sciencedirect.com/science/article/pii/S1470204515005409 |
欢迎光临 科研速递论坛 (http://expaper.cn/) | Powered by Discuz! X2.5 |